We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
MedLink International Inc (CE) | USOTC:MLKNA | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
1
|
NAME OF REPORTING PERSON
|
Galileo Partners, LLC
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A) / / (B) / /
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS*
|
WC
|
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E): / /
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
California
|
|
NUMBER OF SHARES BENEFICIALLY OWNED BY REPORTING PERSON WITH
|
|
7
|
SOLE VOTING POWER
|
6,300,000 (A)
|
|
8
|
SHARED VOTING POWER
|
0
|
|
9
|
SOLE DISPOSITIVE POWER
|
6,300,000 (A)
|
|
10
|
SHARED DISPOSITIVE POWER
|
0
|
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
6,300,000 (A)
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES* / /
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
|
20%(A)
|
|
14
|
TYPE OF REPORTING PERSON*
|
OO (Limited Liability Company)
|
|
(A) See Item 5.
|
Item 1.
|
Security And Issuer.
|
Item 3.
|
Source And Amount Of Funds Or Other Consideration.
|
The total amount of funds used to purchase the Securities was $720,000 and was furnished from the working capital of Galileo.
|
|
Item 4.
|
Purpose Of The Transaction.
|
On February 10, 2010 the Reporting Person received 500,000 Shares pursuant to a consulting arrangement with the Issuer.
|
|
On March 4, 2010 the Reporting Person received 95,000 Shares pursuant to a consulting arrangement with an affiliate.
|
|
On March 11, 2010 the Reporting Person purchased 200 shares of Series A Preferred and a three – year warrant to purchase 200,000 Shares at an exercise price of $1.05 per share (the
Warrants
”)
(1)
for the purchase price of $90,000.
|
|
On April 8, 2010 the Reporting Person purchased an additional 200 shares of Series A Preferred and additional Warrants
(1)
for the purchase price of $90,000.
|
|
On April 23, 2010 the Reporting Person purchased an additional 200 shares of Series A Preferred and additional Warrants
(1)
for the purchase price of $90,000.
|
|
On May 13, 2010 the Reporting Person purchased an additional 200 shares of Series A Preferred and additional Warrants
(1)
for the purchase price of $90,000.
|
|
(1) The Issuer granted the Warrants in May 2010 retroactive to the purchase dates of the Series A Preferred Stock.
|
|
On June 17, 2010 the Reporting Person purchased an additional 200 shares of Series A Preferred and additional Warrants for the purchase price of $90,000.
|
|
On July 22, 2010 the Reporting Person purchased an additional 200 shares of Series A Preferred and additional Warrants for the purchase price of $90,000.
|
|
On July 22, 2010 the Reporting Person received 105,000 Shares pursuant to a consulting arrangement with a non affiliate of the Issuer.
|
Through the period June 21, 2010 through August 19, 2010 the Reporting Person purchased 10,000 Shares in the open market and sold 210,000 Shares in the open market for the sale and purchase prices as set forth on Exhibit 1.
|
|
On August 17, 2010 the Reporting Person purchased an additional 200 shares of Series A Preferred and additional Warrants for the purchase price of $90,000.
|
|
On September 3, 2010 the Reporting Person purchased an additional 200 shares of Series A Preferred and additional Warrants for the purchase price of $90,000.
|
|
On September 16, 2010 the Reporting Person received 2,600,000 Shares pursuant to a consulting agreement.
|
|
Item 5.
|
Interest In Securities Of The Issuer.
|
Galileo is the owners of an aggregate of 6,300,000 Shares (on an as diluted basis), representing approximately 20% of the outstanding Shares (based upon 36,442,236 Shares outstanding as of June 30, 2010, as reported on the latest 10-Q filed by the Issuer and the Warrants referenced herein ).
|
|
Item 6.
|
Contracts, Arrangements, Understandings Or Relationships With Respect To Securities Of The Issuer.
|
Not applicable
|
|
Item 7.
|
Material To Be Filed As Exhibits.
|
Exhibit 1: Schedule of Sales and Purchases of Shares in the open market.
|
DATED: September 24, 2010
|
Galileo Partners, LLC
|
By:
/s/ Steve Antebi
|
|
Steve Antebi, Managing Member
|
Exhibit 1
|
Schedule of Sales and Purchases of Shares in the open market.
|
1 Year MedLink (CE) Chart |
1 Month MedLink (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions